A nanobody is an antibody fragment consisting of a single monomeric variable antigen-binding domain. Mammalian cells are ideal platforms for identifying nanobodies targeting hard-to-display transmembr
Antibody engineering technologies face increasing demands for speed, reliability and scale. We developed CeVICA, a cell-free nanobody engineering platform that uses ribosome display for in vitro selec
